2 Reasons Oracle Stock Could Double in Value by 2028

Oracle’s valuation has reset after the OpenAI-related surge: P/E fell from 76 to 22 (with forward P/E around 16), supported by 37% net income growth in fiscal 2026. Backlog (RPO) rose from $455B at the OpenAI announcement to $638B over the following nine months, suggesting continued AI infrastructure demand beyond that single deal, even as the company borrowed nearly $130B and spent $56B on capex. Despite leverage concerns, the article argues the setup could justify a substantial rerating by 2028 if profits and RPO growth persist.

Analysis

The key market mechanism is that Oracle is no longer being valued like a clean software compounding story; it is increasingly a levered infrastructure buildout. That matters because backlog growth only translates into equity value if cash conversion is fast enough to outrun debt service and depreciation, otherwise the market will keep discounting the earnings line at a much lower multiple than peers.

Second-order beneficiaries are the compute and networking suppliers that get paid regardless of whether every end customer contract proves sticky; that is the cleaner way to express the AI capex theme than owning Oracle outright. The flip side is competitive pricing pressure across cloud providers such as MSFT, AMZN, and GOOGL if Oracle tries to fill capacity aggressively, which can keep industry returns on capital lower even when bookings look strong.

The contrarian miss is that a growing backlog is not the same as de-risked equity: the market may be underpricing the possibility that billings slip while capex and interest expense stay elevated. Over the next 1-3 months, the catalyst is not another press-release booking number but evidence on free cash flow, leverage, and whether management softens capex intensity; over 6-18 months, the thesis flips if Oracle proves it can self-fund the build without perpetual balance-sheet strain. The main falsifier is any quarter where backlog growth slows or FCF fails to inflect despite continued revenue growth.

Key Decisions for Investors

• Avoid initiating a large outright long in ORCL here; wait for the next earnings cycle to confirm that backlog is converting into free cash flow, not just deferred demand. Alert level: if operating cash flow does not cover capex plus interest for two consecutive quarters, treat the equity as a value trap rather than a rerating story.
• Prefer a relative-value expression of the AI capex cycle: long NVDA vs. short ORCL for a 3-6 month horizon. NVDA monetizes the buildout immediately, while ORCL carries execution and leverage risk; thesis is invalidated if Oracle guides capex lower while maintaining backlog growth and improving FCF.
• For investors wanting upside with defined risk, use ORCL call spreads 6-12 months out instead of common stock. Only enter on post-earnings weakness; the trade works if forward valuation stays compressed in the mid-teens and management shows leverage is peaking, and it fails if debt metrics worsen or backlog growth decelerates.
• Watch ORCL credit spreads as the cleaner tell than the equity. If bonds widen while the stock stabilizes, that is a warning that the market is questioning cash conversion; if spreads tighten with improving FCF, the equity rerating can extend.